Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 21, No. 1, 2006   

Free Abstract     Article (References)     Article (PDF 85 KB)     

Paper

A Folate-Dependent Metabolite in Amniotic Fluid from Pregnancies with Normal or Trisomy 21 Chromosomes
Paddy Jim Baggota, b, c, Anna Jane Y. Eliseoc, Jeremy A. Kalamaridesd, James D. Shoemakere

aQueen of Angels Hospital, and
bUniversity of Southern California, Los Angeles, Calif.,
cSanta Teresita Hospital, Duarte, Calif.,
dLake Erie College of Osteopathic Medicine, Erie, Pa., and
eMetabolic Screening Laboratory, Saint Louis University School of Medicine, St. Louis, Mo., USA

Address of Corresponding Author

Fetal Diagn Ther 2006;21:148-152 (DOI: 10.1159/000089066)


 goto top of page Key Words

  • Down syndrome
  • Folic acid
  • Amniotic fluid

 goto top of page Abstract

Introduction: Previous studies have given conflicting results as to whether or not folate metabolism is altered in Down syndrome. Folate is necessary to facilitate metabolism of one-carbon units. Folate accepts one-carbon units from one-carbon unit donors, including formiminoglutamate (FIGLU). Folate deficiency leads to accumulation of FIGLU and impairment of one-carbon unit metabolism. FIGLU is a functional measure of folate deficiency. Materials and Methods: Archived anonymized amniotic fluid specimens were obtained from normal pregnancies and those with Down syndrome. Gas liquid chromatography/mass spectrometry was used to quantitate FIGLU, which is elevated in folate deficiency. A tetra-deuterated FIGLU was used as a standard, and single-ion monitoring was performed. Nonparametric statistical analysis was performed with the Mann-Whitney U test. Results: FIGLU was significantly lower in pregnancies with Down syndrome. The median FIGLU level was 0.9 µmol/l in amniotic fluid from fetuses with Down syndrome. The median FIGLU level was 1.3 in amniotic fluid from control fetuses. This difference was statistically significant (p = 0.009). No statistically significant differences were found with histidine or glutamate. Discussion: There was no evidence of folate deficiency. FIGLU was decreased, not increased. Decreased FIGLU might result from accelerated activity of one or more genes on chromosome 21, by a gene dosage effect. Genes which might explain the reduced FIGLU include one which degrades FIGLU (glutamate formiminotransferase-cyclodeaminase), one which participates in purine synthesis, and one which degrades homocysteine (cystathionine-beta-synthase).

Copyright © 2006 S. Karger AG, Basel


 goto top of page Author Contacts

Paddy Jim Baggot, MD
Santa Teresita Medical Center
931 Buena Vista Street, Suite 301
Duarte, CA 91010 (USA)
Tel. +1 626 358 8045, Fax +1 626 358 8216, E-Mail pjbaggot@hotmail.com


 goto top of page Article Information

Received: May 6, 2004
Accepted after revision: March 20, 2005
Number of Print Pages : 5
Number of Figures : 0, Number of Tables : 1, Number of References : 16

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 16354994)
Download Citation
Cited In



New Editorial Team!

Editor-in-Chief:
E. Gratacós, Barcelona

Associate Editors:
F. Figueras, Barcelona
E. Hernández-Andrade, Mexico
J.A. Hyett, Sydney
L. Lewi, Leuven
R.D. Wilson, Calgary


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2009 S. Karger AG, Basel